Molecular modification of a recombinant anti-CD3ε-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model

D. A. Vallera, D. W. Kuroki, A. Panoskaltsis-Mortari, D. J. Buchsbaum, B. E. Rogers, B. R. Blazar

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Molecular modification of a recombinant anti-CD3ε-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences